A woman uses Alpha-Stim earclips

Treating mood conditions

Treat Anxiety, Insomnia, and Depression with the Alpha-Stim® AID

The Alpha-Stim® AID is a drug-free Cranial Electrotherapy Stimulation (CES) medical device that uses low-level electrical current to safely and effectively treat anxiety, depression, and insomnia. CES was cleared by the FDA in 1992 as a prescriptive, noninvasive treatment. It has an extensive safety record, with few side effects (seen in less than 1% of users and considerable scientific evidence of the significant results patients can achieve.

LET NOTHING STOP THEM.

Treating mood conditions

Treat Anxiety, Insomnia, and Depression with the Alpha-Stim® AID

The Alpha-Stim® AID is a drug-free Cranial Electrotherapy Stimulation (CES) medical device that uses low-level electrical current to safely and effectively treat anxiety, depression, and insomnia. CES was cleared by the FDA in 1992 as a prescriptive, noninvasive treatment. It has an extensive safety record, with few side effects (seen in less than 1% of users and considerable scientific evidence of the significant results patients can achieve.

LET NOTHING STOP THEM.

Buy Now

The Alpha-Stim uses small earclips that provide Cranial Electrotherapy Stimulation (CES) to treat anxiety, insomnia, and depression. Using a patented waveform, Alpha-Stim is proven safe and effective by more than 100 studies over the past 38 years.

  • Alpha-Stim can be used as a first-line therapy for pain management, or as an adjunct to pharmacotherapy without polypharmacy effects
  • Alpha-Stim technology is safe, with no serious adverse events reported in over 38 years of clinical use
  • Alpha-Stim treatments are cumulative; however, most patients show at least some improvement after the first treatment

The fundamentals: An electrical intervention

  • The brain and nervous system function electrochemically and can be readily modulated by electrical intervention1,2
  • Alpha-Stim microcurrent electrical therapy and cranial electrotherapy stimulation impacts electrochemical function at the cellular level

The Alpha-Stim advantage: A patented waveform

  • The only rigorously tested waveform designed and refined to improve effectiveness
  • Delivers a very low level of current in pulsed microcurrents of less than one milliampere
  • Effectively targets cell receptors, activating them through frequency matching in a manner similar to chemical ligands

The results: Significant improvement, quickly, with lasting effect

Electroencephalographic studies show:

  • Increased alpha activity
  • Decreased delta activity
  • Decreased beta activity

As the leader in CES therapy, Alpha-Stim has helped clinicians around the world provide fast, safe, and effective relief from anxiety, depression, and insomnia.

qEEG changes in 30 subjects treated with 20 minutes of Alpha Stim CES. There is an increase (Red) in alpha activity with a simultaneous decrease (Blue) in beta and delta2.

Click here to see a complete Alpha-Stim bibliography
VIEW PRODUCT BROCHURE

(multilingual options available)

Let us help you get started! To have an Alpha-Stim representative contact you, complete the following form:

We offer free trials to practitioners for in-office use. Typically, an in-office or clinic trial can identify those individuals who readily respond to Alpha-Stim treatment. You or your patients can fulfill your order from our online store.

For more questions or details on special practitioner pricing, contact us at 1-(800) FOR-PAIN (in the US), + (940) 328-0788 (outside the US) or by emailing us at info@epii.com. You may also fax your order to us at +(940) 328-0888.

  • This field is for validation purposes and should be left unchanged.
  1. Heffernan M. Comparative effects of microcurrent stimulation on EEG spectrum and correlation dimension. Integrative Physiological and Behavioral Science. 1996; 31(3):202-209.
  2. Kennerly R. Changes in quantitative EEG and low resolution tomography following cranial electrotherapy stimulation. PhD Dissertation, the University of North Texas. 2006;529 pp., 81 tables, 233 figures, 171 references.